Dennis M Lanfear insider trades
Open-market stock purchases and sales by Dennis M Lanfear, President & CEO at Coherus Oncology, Inc, from SEC Form 4 filings since Jun 9, 2010.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 29, 2026 | CHRS Coherus Oncology, Inc | Sold (not open market) | $2.5M |
| May 29, 2026 | CHRS Coherus Oncology, Inc | Sold (not open market) | $4M |
| May 29, 2026 | CHRS Coherus Oncology, Inc | Sold (not open market) | $5.6M |
| May 29, 2026 | CHRS Coherus Oncology, Inc | Sold (not open market) | $9.2M |
| May 29, 2026 | CHRS Coherus Oncology, Inc | Sold (not open market) | $2.2M |
| May 29, 2026 | CHRS Coherus Oncology, Inc | Sold (not open market) | $4.2M |
| May 29, 2026 | CHRS Coherus Oncology, Inc | Sold (not open market) | $1.2M |
| May 29, 2026 | CHRS Coherus Oncology, Inc | Bought (not open market) | $318K |
| May 29, 2026 | CHRS Coherus Oncology, Inc | Bought (not open market) | $636K |
| May 29, 2026 | CHRS Coherus Oncology, Inc | Bought (not open market) | $716K |
| May 29, 2026 | CHRS Coherus Oncology, Inc | Bought (not open market) | $795K |
| May 29, 2026 | CHRS Coherus Oncology, Inc | Bought (not open market) | $199K |
| May 29, 2026 | CHRS Coherus Oncology, Inc | Bought (not open market) | $640K |
| May 29, 2026 | CHRS Coherus Oncology, Inc | Bought (not open market) | $358K |
| Jan 23, 2026 | CHRS Coherus Oncology, Inc | Bought (not open market) | — |
| Jan 23, 2026 | CHRS Coherus Oncology, Inc | Bought (not open market) | — |
| Jan 20, 2026 | CHRS Coherus Oncology, Inc | Sold (not open market) | $18.4K |